Nanoparticle Brain Delivery: A Guide to Verification Methods

References

• Sanovich E , BartusRT, FridenPMet al. Pathway across blood–brain barrier opened by the bradykinin agonist, RMP-7. Brain Res.705(1–2), 125–135 (1995).
   PubMed Web of Science ®Google Scholar
• Burke MJC , NelsonL, SladeJYet al. Morphometry of the hippocampal microvasculature in post-stroke and age-related dementias. Neuropathol. Appl. Neurobiol.40(3), 284–295 (2014).
   PubMed Web of Science ®Google Scholar
• Zlokovic BV , ApuzzoML. Strategies to circumvent vascular barriers of the central nervous system. Neurosurgery43(4), 877–878 (1998).
   PubMed Web of Science ®Google Scholar
• Boström M , HellstroemErkenstam N, KaluzaDet al. The hippocampal neurovascular niche during normal development and after irradiation to the juvenile mouse brain. Int. J. Radiat. Biol.90(9), 778–789 (2014).
   PubMed Web of Science ®Google Scholar
• Ohno K , PettigrewKD, RapoportSI. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am. J. Physiol.235(3), H299–H307 (1978).
   PubMedGoogle Scholar
• Calvo P , GouritinB, ChacunHet al. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm. Res.18(8), 1157–1166 (2001).
   PubMed Web of Science ®Google Scholar
• Weiss N , MillerF, CazaubonS, CouraudP-O. The blood–brain barrier in brain homeostasis and neurological diseases. Biochim. Biophys. Acta, Biomembr.1788(4), 842–857 (2009).
   PubMed Web of Science ®Google Scholar
• Rosenberg GA . Neurological diseases in relation to the blood–brain barrier. J. Cereb. Blood Flow Metab.32(7), 1139–1151 (2012).
   PubMed Web of Science ®Google Scholar
• Bellavance M-A , BlanchetteM, FortinD. Recent advances in blood–brain barrier disruption as a CNS delivery strategy. AAPS J.10(1), 166–177 (2008).
   PubMed Web of Science ®Google Scholar
• Burgess A , HynynenK. Microbubble-assisted ultrasound for drug delivery in the brain and central nervous system. Adv. Exp. Med. Biol.880, 293–308 (2016).
   PubMed Web of Science ®Google Scholar
• Frigell J , GarciaI, Gomez-VallejoV, LlopJ, PenadesS. 68Ga-labeled gold glyconanoparticles for exploring blood–brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation. J. Am. Chem. Soc.136(1), 449–457 (2014).
   PubMed Web of Science ®Google Scholar
• Sela H , EliaP, ZachRet al. Spontaneous penetration of gold nanoparticles through the blood brain barrier (BBB). J. Nanobiotechnol.13, 71 (2015).
   PubMed Web of Science ®Google Scholar
• Gage GJ , KipkeDR, ShainW. Whole animal perfusion fixation for rodents. J. Vis. Exp.65(65), 3564 (2012).
   Google Scholar
• Buzulukov YP , ArianovaEA, DeminVFet al. Bioaccumulation of silver and gold nanoparticles in organs and tissues of rats studied by neutron activation analysis. Biol. Bull.41(3), 255–263 (2014).
   Google Scholar
• Schleh C , Semmler-BehnkeM, LipkaJet al. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology6, 36–46 (2012).
   PubMed Web of Science ®Google Scholar
• Yokel RA , TsengMT, DanMet al. Biodistribution and biopersistence of ceria engineered nanomaterials: size dependence. Nanomedicine9(3), 398–407 (2013).
   PubMed Web of Science ®Google Scholar
• Schäffler M , SousaF, WenkAet al. Blood protein coating of gold nanoparticles as potential tool for organ targeting. Biomaterials35(10), 3455–3466 (2014).
   PubMed Web of Science ®Google Scholar
• Hirn S , Semmler-BehnkeM, SchlehCet al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur. J. Pharm. Biopharm.77(3), 407–416 (2011).
   PubMed Web of Science ®Google Scholar
• Gessner A , OlbrichC, SchroderW, KayserO, MullerRH. The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. Int. J. Pharm.214(1–2), 87–91 (2001).
   PubMed Web of Science ®Google Scholar
• Baghirov H , KaramanD, ViitalaTet al. Feasibility study of the permeability and uptake of mesoporous silica nanoparticles across the blood-brain barrier. PLoS ONE11(8), e0160705 (2016).
   PubMed Web of Science ®Google Scholar
• Dan M , TsengMT, WuPet al. Brain microvascular endothelial cell association and distribution of a 5 nm ceria engineered nanomaterial. Int. J. Nanomed.7, 4023–4036 (2012).
   PubMed Web of Science ®Google Scholar
• Sanavio B , LibrizziL, PennacchioPet al. Distribution of superparamagnetic Au/Fe nanoparticles in an isolated guinea pig brain with an intact blood brain barrier. Nanoscale10(47), 22420–22428 (2018).
   PubMed Web of Science ®Google Scholar
• Wilhelm C , GazeauF, RogerJ, PonsJN, BacriJC. Interaction of anionic superparamagnetic nanoparticles with cells: kinetic analyses of membrane adsorption and subsequent internalization. Langmuir18(21), 8148–8155 (2002).
   Web of Science ®Google Scholar
• Fiandra L , ColomboM, MazzucchelliSet al. Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice. Nanomedicine11(6), 1387–1397 (2015).
   PubMed Web of Science ®Google Scholar
• Dal Magro R , AlbertiniB, BerettaSet al. Artificial apolipoprotein corona enables nanoparticle brain targeting. Nanomedicine14(2), 429–438 (2018).
   PubMed Web of Science ®Google Scholar
• Healy AT , VogelbaumMA. Convection-enhanced drug delivery for gliomas. Surg. Neurol. Int.6(Suppl. 1), S59–S67 (2015).
   PubMedGoogle Scholar
• Lonser RR , SarntinoranontM, MorrisonPF, OldfieldEH. Convection-enhanced delivery to the central nervous system. J. Neurosurg.122(3), 697–706 (2015).
   PubMed Web of Science ®Google Scholar
• Mehta AM , SonabendAM, BruceJN. Convection-enhanced delivery. Neurotherapeutics14(2), 358–371 (2017).
   PubMed Web of Science ®Google Scholar
• Singh R , WangM, SchweitzerMEet al. Volume of distribution and clearance of peptide-based nanofiber after convection-enhanced delivery. J. Neurosurg.129(1), 10–18 (2018).
   PubMed Web of Science ®Google Scholar
• Liu Q , ShenY, ChenJet al. Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles. Pharm. Res.29(2), 546–558 (2012).
   PubMed Web of Science ®Google Scholar
• De Lorenzo AJD . The olfactory neuron and the blood–brain barrier. In: Taste and Smell in Vertebrates. WolstenholmeG, KnightJ ( Eds). Churchhill, London, UK, 151–176 (1970).
   Google Scholar
• Gopinath PG , GopinathG, KumarTCA. Target site of intranasally sprayed substances and their transport across the nasal mucosa: a new insight into the intransal route of drug-delivery. Curr. Ther. Res.23(5), 596–607 (1978).
   Web of Science ®Google Scholar
• Oberdörster G , SharpZ, AtudoreiVet al. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol.16(6–7), 437–445 (2004).
   PubMed Web of Science ®Google Scholar
• Elder A , GeleinR, SilvaVet al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect.114(8), 1172–1178 (2006).
   PubMed Web of Science ®Google Scholar
• Hopkins LE , PatchinES, ChiuP-Let al. Nose-to-brain transport of aerosolised quantum dots following acute exposure. Nanotoxicology8(8), 885–893 (2014).
   PubMed Web of Science ®Google Scholar
• Migliore MM , VyasTK, CampbellRB, AmijiMM, WaszczakBL. Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations. J. Pharm. Sci.99(4), 1745–1761 (2010).
   PubMed Web of Science ®Google Scholar
• Wang D , WuY, XiaJ. Review on photoacoustic imaging of the brain using nanoprobes. Neurophotonics3(1), 010901 (2016).
   PubMed Web of Science ®Google Scholar
• Baddeley D , BewersdorfJ. Biological insight from super-resolution microscopy: what we can learn from localization-based images. Annu. Rev. Biochem.87, 965–989 (2018).
   PubMed Web of Science ®Google Scholar
• Feiner-Gracia N , BeckM, PujalsSet al. Super-resolution microscopy unveils dynamic heterogeneities in nanoparticle protein corona. Small13(41), 1701631 (2017).
   Web of Science ®Google Scholar
• Clemments AM , BotellaP, LandryCC. Spatial mapping of protein adsorption on mesoporous silica nanoparticles by stochastic optical reconstruction microscopy. J. Am. Chem. Soc.139(11), 3978–3981 (2017).
   PubMed Web of Science ®Google Scholar
• Van Der Zwaag D , VanparijsN, WijnandsSet al. Super resolution imaging of nanoparticles cellular uptake and trafficking. ACS Appl. Mater. Interfaces8(10), 6391–6399 (2016).
   PubMed Web of Science ®Google Scholar
• Fumagalli G , MazzaD, ChristodoulouMSet al. Cyclopamine-paclitaxel-containing nanoparticles: internalization in cells detected by confocal and super-resolution microscopy. ChemPlusChem80(9), 1380–1383 (2015).
   PubMed Web of Science ®Google Scholar
• Patskovsky S , BergeronE, RiouxD, MeunierM. Wide-field hyperspectral 3D imaging of functionalized gold nanoparticles targeting cancer cells by reflected light microscopy. J. Biophotonics8(5), 401–407 (2015).
   PubMed Web of Science ®Google Scholar
• Roth GA , TahilianiS, Neu-BakerNM, BrennerSA. Hyperspectral microscopy as an analytical tool for nanomaterials. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.7(4), 565–579 (2015).
   PubMed Web of Science ®Google Scholar
• Pena MDPS , GottipatiA, TahilianiSet al. Hyperspectral imaging of nanoparticles in biological samples: simultaneous visualization and elemental identification. Microsc. Res. Tech.79(5), 349–358 (2016).
   PubMed Web of Science ®Google Scholar
• Mulik RS , BingC, Ladouceur-WodzakMet al. Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasound. Biomaterials83, 257–268 (2016).
   PubMed Web of Science ®Google Scholar
• Åslund AKO , BergS, HakSet al. Nanoparticle delivery to the brain – by focused ultrasound and self-assembled nanoparticle-stabilized microbubbles. J. Control. Rel.220(Part A), 287–294 (2015).
   PubMedGoogle Scholar
• Yang T , MartinP, FogartyBet al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio Rerio. Pharm. Res.32(6), 2003–2014 (2015).
   PubMed Web of Science ®Google Scholar
• Han L , KongDK, ZhengM-Qet al. Increased nanoparticle delivery to brain tumors by autocatalytic priming for improved treatment and imaging. ACS Nano10(4), 4209–4218 (2016).
   PubMed Web of Science ®Google Scholar
• Kundu P , DasM, TripathyK, SahooSK. Delivery of dual drug loaded lipid based nanoparticles across the blood–brain barrier impart enhanced neuroprotection in a rotenone induced mouse model of parkinson’s disease. ACS Chem. Neurosci.7(12), 1658–1670 (2016).
   PubMed Web of Science ®Google Scholar
• Ko YT . Nanoparticle-mediated delivery of oligonucleotides to the blood–brain barrier: in vitro and in situ brain perfusion studies on the uptake mechanisms. J. Drug Target.21(9), 866–873 (2013).
   PubMed Web of Science ®Google Scholar
• Hu X , YangF, LiaoY, LiL, ZhangL. Cholesterol-PEG comodified poly(N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations. Drug Deliv.24(1), 121–132 (2017).
   PubMed Web of Science ®Google Scholar
• Liang J , GaoC, ZhuYet al. Natural brain penetration enhancer-modified albumin nanoparticles for glioma targeting delivery. ACS Appl. Mater. Interfaces10(36), 30201–30213 (2018).
   PubMed Web of Science ®Google Scholar
• Tamba BI , StreinuV, FolteaGet al. Tailored surface silica nanoparticles for blood–brain barrier penetration: preparation and in vivo investigation. Arabian J. Chem.11(6), 981–990 (2018).
   Web of Science ®Google Scholar
• Yang J-T , KuoY-C, ChenIYet al. Protection against neurodegeneration in the hippocampus using sialic acid- and 5-HT-moduline-conjugated lipopolymer nanoparticles. ACS Biomater. Sci. Eng.5(3), 1311–1320 (2019).
   PubMed Web of Science ®Google Scholar
• Rasmussen K , GonzálezM, KearnsPet al. Review of achievements of the OECD Working Party on Manufactured Nanomaterials’ Testing and Assessment Programme. From exploratory testing to test guidelines. Regul. Toxicol. Pharmacol.74, 147–160 (2016).
   PubMed Web of Science ®Google Scholar
• Lin P-C , LinS, WangPC, SridharR. Techniques for physicochemical characterization of nanomaterials. Biotechnol. Adv.32(4), 711–726 (2014).
   PubMed Web of Science ®Google Scholar
• Manaia EB , AbuçafyMP, Chiari-AndréoBGet al. Physicochemical characterization of drug nanocarriers. Int. J. Nanomed.12, 4991–5011 (2017).
   PubMed Web of Science ®Google Scholar
• Agronskaia AV , ValentijnJA, Van DrielLFet al. Integrated fluorescence and transmission electron microscopy. J. Struct. Biol.164(2), 183–189 (2008).
   PubMed Web of Science ®Google Scholar
• Kempen PJ , KircherMF, DeLa Zerda Aet al. A correlative optical microscopy and scanning electron microscopy approach to locating nanoparticles in brain tumors. Micron68, 70–76 (2015).
   PubMed Web of Science ®Google Scholar
• Han S , RaabeM, HodgsonLet al. High-contrast imaging of nanodiamonds in cells by energy filtered and correlative light-electron microscopy: toward a quantitative nanoparticle-cell analysis. Nano Lett.19(3), 2178–2185 (2019).
   PubMed Web of Science ®Google Scholar
• Weiss B , SchaeferUF, ZappJet al. Nanoparticles made of fluorescence-labelled poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility. J. Nanosci. Nanotechnol.6(9–10), 3048–3056 (2006).
   PubMed Web of Science ®Google Scholar
• Zandanel C , VauthierC. Characterization of fluorescent poly(isobutylcyanoacrylate) nanoparticles obtained by copolymerization of a fluorescent probe during Redox Radical Emulsion Polymerization (RREP). Eur. J. Pharm. Biopharm.82(1), 66–75 (2012).
   PubMed Web of Science ®Google Scholar
• Li K , LiuB. Polymer-encapsulated organic nanoparticles for fluorescence and photoacoustic imaging. Chem. Soc. Rev.43(18), 6570–6597 (2014).
   PubMed Web of Science ®Google Scholar
• Reisch A , KlymchenkoAS. Fluorescent polymer nanoparticles based on dyes: seeking brighter tools for bioimaging. Small12(15), 1968–1992 (2016).
   PubMed Web of Science ®Google Scholar
• Takasato Y , RapoportSI, SmithQR. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol.247(3 Pt 2), H484–H493 (1984).
   PubMed Web of Science ®Google Scholar
• Triguero D , BuciakJ, PardridgeWM. Capillary depletion method for quantification of blood–brain barrier transport of circulating peptides and plasma proteins. J. Neurochem.54(6), 1882–1888 (1990).
   PubMed Web of Science ®Google Scholar
• Yokel RA . Methods to quantify nanomaterial association with, and distribution across, the blood–brain barrier in vivo. In: Nanotoxicity: Methods and Protocols. ZhangQ ( Ed.). Springer, NY, USA, 281–299 (2018).
   Google Scholar
• Wohlfart S , KhalanskyAS, GelperinaS, BegleyD, KreuterJ. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier. J. Control. Rel.154, 103–107 (2011).
   PubMed Web of Science ®Google Scholar
• Kafa H , WangJT-W, RubioNet al. The interaction of carbon nanotubes with an in vitro blood–brain barrier model and mouse brain in vivo. Biomaterials53, 437–452 (2015).
   PubMed Web of Science ®Google Scholar
• Ramalingam P , KoYT. Enhanced oral delivery of curcumin from n-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations. Pharm. Res.32(2), 389–402 (2015).
   PubMed Web of Science ®Google Scholar
• Pang Z , GaoH, ChenJet al. Intracellular delivery mechanism and brain delivery kinetics of biodegradable cationic bovine serum albumin-conjugated polymersomes. Int. J. Nanomed.7, 3421–3432 (2012).
   PubMed Web of Science ®Google Scholar
• Johnsen KB , BakM, MelanderFet al. Modulating the antibody density changes the uptake and transport at the blood–brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo. J. Control. Rel.295, 237–249 (2019).
   PubMed Web of Science ®Google Scholar
• Bommana MM , KirthivasanB, SquillanteE. In vivo brain microdialysis to evaluate FITC-dextran encapsulated immunopegylated nanoparticles. Drug Deliv.19(6), 298–306 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang X , LiuL, ChaiG, ZhangX, LiF. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats. Drug Dev. Ind. Pharm.39(11), 1618–1624 (2013).
   PubMed Web of Science ®Google Scholar
• Liu Z , OkekeCI, ZhangLet al. Mixed polyethylene glycol-modified breviscapine-loaded solid lipid nanoparticles for improved brain bioavailability: preparation, characterization, and in vivo cerebral microdialysis evaluation in adult Sprague Dawley rats. AAPS PharmSciTech15(2), 483–496 (2014).
   PubMed Web of Science ®Google Scholar
• Zhu J , ZouJ, MuCet al. Intranasal administration of pullulan-based nanoparticles for enhanced delivery of adriamycin into the brain: in vitro and in vivo evaluation. Pharmazie74(1), 39–46 (2019).
   PubMed Web of Science ®Google Scholar
• Al Zaki A , HuiJZ, HigbeeE, TsourkasA. Biodistribution, clearance, and toxicology of polymeric micelles loaded with 0.9 or 5 nm gold nanoparticles. J. Biomed. Nanotechnol.11(10), 1836–1846 (2015).
   PubMed Web of Science ®Google Scholar
• Krauze MT , NobleCO, KawaguchiTet al. Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts. Neuro-Oncol.9(4), 393–403 (2007).
   PubMed Web of Science ®Google Scholar
• Corem-Salkmon E , RamZ, DanielsDet al. Convection-enhanced delivery of methotrexate-loaded maghemite nanoparticles. Int. J. Nanomed.6, 1595–1602 (2011).
   PubMed Web of Science ®Google Scholar
• Noble CO , KrauzeMT, DrummondDCet al. Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Res.66(5), 2801–2806 (2006).
   PubMed Web of Science ®Google Scholar
• Oppong-Damoah A , ZamanRU, D’SouzaMJ, MurnaneKS. Nanoparticle encapsulation increases the brain penetrance and duration of action of intranasal oxytocin. Horm. Behav.108, 20–29 (2019).
   PubMed Web of Science ®Google Scholar
• Mackay JA , DeenDF, SzokaFC. Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating. Brain Res.1035(2), 139–153 (2005).
   PubMed Web of Science ®Google Scholar
• Saito R , KrauzeMT, NobleCOet al. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro-Oncol.8(3), 205–214 (2006).
   PubMed Web of Science ®Google Scholar
• French JT , GoinsB, SaenzMet al. Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide. J. Vasc. Interv. Radiol.21(8), 1271–1279 (2010).
   PubMed Web of Science ®Google Scholar
• Weng KC , HashizumeR, NobleCOet al. Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models. Nanomedicine (Lond.)8(12), 1913–1925 (2013).
   PubMed Web of Science ®Google Scholar
• Sirianni RW , ZhengM-Q, PatelTRet al. Radiolabeling of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with biotinylated F-18 prosthetic groups and imaging of their delivery to the brain with positron emission tomography. Bioconjug. Chem.25(12), 2157–2165 (2014).
   PubMed Web of Science ®Google Scholar
• Arshad A , YangB, BienemannASet al. Convection-enhanced delivery of carboplatin PLGA nanoparticles for the treatment of glioblastoma. PLoS ONE10(7), e0132266 (2015).
   PubMed Web of Science ®Google Scholar
• Chen EM , QuijanoAR, SeoY-Eet al. Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors. Biomaterials178, 193–203 (2018).
   PubMed Web of Science ®Google Scholar
• Stephen ZR , ReviaRA, WangKet al. Time-resolved MRI assessment of convection-enhanced delivery by targeted and non-targeted nanoparticles in a human glioblastoma mouse model. Cancer Res.79(18), 4776–4786 (2019).
   PubMed Web of Science ®Google Scholar
• Stucht D , DanishadKA, SchulzePet al. Highest resolution in vivo human brain MRI using prospective motion correction. PLoS ONE10(7), e0133921 (2015).
   PubMed Web of Science ®Google Scholar
• IVIS Imaging Systems (2019). www.Perkinelmer.Com/Lab-Solutions/Resources/Docs/Sht_011713c_01_Ivis_Comparison_Table.Pdf
   Google Scholar
• Barré FPY , HeerenRMA, PotočnikNO. Mass Spectrometry imaging in nanomedicine: unraveling the potential of MSI for the detection of nanoparticles in neuroscience. Curr. Pharm. Des.23(13), 1974–1984 (2017).
   PubMed Web of Science ®Google Scholar
• Ries J , KaplanC, PlatonovaE, EghlidiH, EwersH. A simple, versatile method for GFP-based super-resolution microscopy via nanobodies. Nat. Methods9(6), 582–584 (2012).
   PubMed Web of Science ®Google Scholar
• Dudok B , BarnaL, LedriMet al. Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nat. Neurosci.18(1), 75–86 (2015).
   PubMed Web of Science ®Google Scholar
• Herrmannsdorfer F , FlottmanB, NanguneriSet al. 3D D STORM imaging of fixed brain tissue. Methods Mol. Biol.1538, 169–184 (2017).
   PubMedGoogle Scholar
• Wen C-J , ZhangL-W, Al-SuwayehSA, YenT-C, FangJ-Y. Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging. Int. J. Nanomed.7, 1599–1611 (2012).
   PubMed Web of Science ®Google Scholar
• Singh-Moon RP , RoblyerDM, BigioIJ, JoshiS. Spatial mapping of drug delivery to brain tissue using hyperspectral spatial frequency-domain imaging. J. Biomed. Opt.19(9), 96003 (2014).
   PubMed Web of Science ®Google Scholar
• Mitkovski M , Padovan-NetoFE, Raisman-VozariRet al. Investigations into potential extrasynaptic communication between the dopaminergic and nitrergic systems. Front. Physiol. Membr. Physiol. Biophys.3(Sept.), 372 (2012).
   PubMedGoogle Scholar
• Malatesta M . Transmission electron microscopy for nanomedicine: novel applications for long-established techniques. Eur. J. Histochem.60(4), 280–284 (2016).
   Web of Science ®Google Scholar
• Tröster SD , MüllerU, KreuterJ. Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants. Int. J. Pharm.61(1–2), 85–100 (1990).
   Google Scholar
• Fundarò A , CavalliR, BargoniAet al. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. Pharmacol. Res.42(4), 337–343 (2000).
   PubMed Web of Science ®Google Scholar
• Gao K , JiangX. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Int. J. Pharm.310(1–2), 213–219 (2006).
   PubMedGoogle Scholar
• Chen Y-S , HungY-C, LinL-Wet al. Size-dependent impairment of cognition in mice caused by the injection of gold nanoparticles. Nanotechnol.21, 485102/485101–485102/485109 (2010).
   Web of Science ®Google Scholar
• Guerrero S , ArayaE, FiedlerJLet al. Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide. Nanomedicine (Lond.)5, 897–913 (2010).
   PubMed Web of Science ®Google Scholar
• Liu H-L , HuaM-Y, YangH-Wet al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc. Natl Acad. Sci. USA107(34), 15205-10– (2010).
   PubMed Web of Science ®Google Scholar
• Tsai Y-M , ChienC-F, LinL-C, TsaiT-H. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood–brain barrier penetration. Int. J. Pharm.416(1), 331–338 (2011).
   PubMed Web of Science ®Google Scholar
• Wen C-J , YenT-C, Al-SuwayehSA, ChangH-W, FangJ-Y. In vivo real-time fluorescence visualization and brain-targeting mechanisms of lipid nanocarriers with different fatty ester:oil ratios. Nanomedicine (Lond.)6(9), 1545–1559 (2011).
   PubMed Web of Science ®Google Scholar
• Wen Z , YanZ, HeRet al. Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration. Drug Deliv.18(8), 555–561 (2011b).
   PubMed Web of Science ®Google Scholar
• Dziendzikowska K , Gromadzka-OstrowskaJ, LankoffAet al. Time-dependent biodistribution and excretion of silver nanoparticles in male Wistar rats. J. Appl. Toxicol.32(11), 920–928 (2012).
   PubMed Web of Science ®Google Scholar
• Prades R , GuerreroS, ArayaEet al. Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor. Biomaterials33(29), 7194–7205 (2012).
   PubMed Web of Science ®Google Scholar
• Martins SM , SarmentoB, NunesCet al. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration. Eur. J. Pharm. Biopharm.85(3PA), 488–502 (2013).
   PubMedGoogle Scholar
• Mazza M , NotmanR, AnwarJet al. Nanofiber-based delivery of therapeutic peptides to the brain. ACS Nano7(2), 1016–1026 (2013).
   PubMed Web of Science ®Google Scholar
• Chaturvedi M , KaczmarekL, MolinoY, SreedharB, KhrestchatiskyM. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier. Int. J. Nanomed.9, 575–588 (2014).
   PubMed Web of Science ®Google Scholar
• Chen Y-C , ChiangC-F, ChenL-Fet al. Polymersomes conjugated with des-octanoyl ghrelin and folate as a BBB-penetrating cancer cell-targeting delivery system. Biomaterials35(13), 4066–4081 (2014).
   PubMed Web of Science ®Google Scholar
• Jose S , SowmyaS, CinuTAet al. Surface modified PLGA nanoparticles for brain targeting of bacoside-A. Eur. J. Pharm. Sci.63, 29–35 (2014).
   PubMed Web of Science ®Google Scholar
• Joachim E , KimI-D, JinYet al. Gelatin nanoparticles enhance the neuroprotective effects of intranasally administered osteopontin in rat ischemic stroke model. Drug Del. Trans. Res.4(5–6), 395–399 (2014).
   PubMed Web of Science ®Google Scholar
• Shilo M , MotieiM, HanaP, PopovtzerR. Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications. Nanoscale6(4), 2146–2152 (2014).
   PubMed Web of Science ®Google Scholar
• Wang B , LvL, WangZet al. Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis. Biomaterials35(22), 5897–5907 (2014).
   PubMed Web of Science ®Google Scholar
• Wang JTW , FabbroC, VenturelliEet al. The relationship between the diameter of chemically-functionalized multi-walled carbon nanotubes and their organ biodistribution profiles in vivo. Biomaterials35(35), 9517–9528 (2014).
   PubMed Web of Science ®Google Scholar
• Yang L , KuangH, ZhangWet al. Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice. Nanoscale7(2), 625–636 (2015).
   PubMed Web of Science ®Google Scholar
• Yadav S , GattaccecaF, PanicucciR, AmijiMM. Comparative biodistribution and pharmacokinetic analysis of cyclosporine-A in the brain upon intranasal or intravenous administration in an oil-in-water nanoemulsion formulation. Mol. Pharm.12(5), 1523–1533 (2015).
   PubMedGoogle Scholar
• Joo J , KwonEJ, KangJet al. Porous silicon-graphene oxide core-shell nanoparticles for targeted delivery of siRNA to the injured brain. Nanoscale Horiz.1(5), 407–414 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang C , LiuQ, ShaoX, QianY, ZhangQ. Phage-displayed peptide-conjugated biodegradable nanoparticles enhanced brain drug delivery. Mater. Lett.167, 213–217 (2016).
   Web of Science ®Google Scholar
• Ruan S , HuC, TangXet al. Increased gold nanoparticle retention in brain tumors by in situ enzyme-induced aggregation. ACS Nano10(11), 10086–10098 (2016).
   PubMed Web of Science ®Google Scholar
• Shah B , KhuntD, MisraM, PadhH. Application of Box–Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route. Int. J. Biol. Macromol.89, 206–218 (2016).
   PubMed Web of Science ®Google Scholar
• Belhadj Z , YingM, WeiXet al. Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment. Oncotarget8(40), 66889–66900 (2017).
   PubMedGoogle Scholar
• Betzer O , ShiloM, OpochinskyRet al. The effect of nanoparticle size on the ability to cross the blood–brain barrier: an in vivo study. Nanomedicine (Lond.)12(13), 1533–1546 (2017).
   PubMed Web of Science ®Google Scholar
• Bouchoucha M , BéliveauÉ, KleitzF, CalonF, FortinM-A. Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting. J. Mater. Chem. B5(37), 7721–7735 (2017).
   PubMed Web of Science ®Google Scholar
• Ghadiri M , Vasheghani-FarahaniE, AtyabiFet al. Transferrin-conjugated magnetic dextran-spermine nanoparticles for targeted drug transport across blood-brain barrier. J. Biomed. Mater. Res. A105(10), 2851–2864 (2017).
   PubMed Web of Science ®Google Scholar
• Velasco-Aguirre C , Morales-ZavalaF, Salas-HuenuleoEet al. Improving gold nanorod delivery to the central nervous system by conjugation to the shuttle Angiopep-2. Nanomedicine (Lond.)12(20), 2503–2517 (2017).
   PubMed Web of Science ®Google Scholar
• Ishak RaH , MostafaNM, KamelAO. Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery – comparative study with the gold standard (Tween 80): optimization, characterization and biodistribution. Drug Deliv.24(1), 1874–1890 (2017).
   PubMed Web of Science ®Google Scholar
• Kumar P , SharmaG, KumarRet al. Stearic acid based, systematically designed oral lipid nanoparticles for enhanced brain delivery of dimethyl fumarate. Nanomedicine (Lond.)12(23), 2607–2621 (2017).
   PubMed Web of Science ®Google Scholar
• Ammar HO , GhorabMM, MahmoudAA, HigazyIM. Lamotrigine loaded poly-ε-(D,L-lactide-co-caprolactone) nanoparticles as brain delivery system. Eur. J. Pharm. Sci.115, 77–87 (2018).
   PubMed Web of Science ®Google Scholar
• Chan TG , MorseSV, CoppingMJ, ChoiJJ, VilarR. Targeted delivery of DNA–Au nanoparticles across the blood–brain barrier using focused ultrasound. ChemMedChem13(13), 1311–1314 (2018).
   PubMed Web of Science ®Google Scholar
• Dutta L , MukherjeeB, ChakrabortyTet al. Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood–brain barrier into brain. Drug Deliv.25(1), 504–516 (2018).
   PubMed Web of Science ®Google Scholar
• Fernandes J , GhateMV, BasuMallik S, LewisSA. Amino acid conjugated chitosan nanoparticles for the brain targeting of a model dipeptidyl peptidase-4 inhibitor. Int. J. Pharm.547(1–2), 563–571 (2018).
   PubMedGoogle Scholar
• Li HY , ZhangB, ChanPSet al. Convergent synthesis and characterization of fatty acid-conjugated poly(ethylene glycol)-block-poly(epsilon-caprolactone) nanoparticles for improved drug delivery to the brain. Eur. Polym. J.98, 394–401 (2018).
   Web of Science ®Google Scholar
• Graverini G , PiazziniV, LanducciEet al. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. Colloids Surf. B161, 302–313 (2018).
   PubMed Web of Science ®Google Scholar
• Najafabadi RE , KazemipourN, EsmaeiliA, BeheshtiS, NazifiS. Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain. BMC Pharmacol. Toxicol.19(1), 59 (2018).
   PubMedGoogle Scholar
• Pandey PK , SharmaAK, RaniSet al. MCM-41 nanoparticles for brain delivery: better choline-esterase and amyloid formation inhibition with improved kinetics. ACS Biomater. Sci. Eng.4(8), 2860–2869 (2018).
   PubMed Web of Science ®Google Scholar
• Chen Y , XuC, YuB, FanH, HuW. Efficient cholera toxin B subunit-based nanoparticles with MRI capability for drug delivery to the brain following intranasal administration. Macromol. Biosci.19(2), e1800340 (2019).
   PubMed Web of Science ®Google Scholar
• Ha S-W , ChoA-S, KimTYet al. Ultrasound-sensitizing nanoparticle complex for overcoming the blood-brain barrier: an effective drug delivery system. Int. J. Nanomed.14, 3743–3752 (2019).
   PubMed Web of Science ®Google Scholar
• Israel LL , BraubachO, GalstyanAet al. A combination of tri-Leucine and angiopep-2 drives a polyanionic polymalic acid nanodrug platform across the blood–brain barrier. ACS Nano13(2), 1253–1271 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang T , LipH, HeCet al. Multitargeted nanoparticles deliver synergistic drugs across the blood–brain barrier to brain metastases of triple negative breast cancer cells and tumor-associated macrophages. Adv. Healthcare Mat.8(18), e1900543 (2019).
   PubMed Web of Science ®Google Scholar